Unicycive gets second CRL for kidney drug as manufacturing woes continuenews2026-06-30T12:55:31+00:00June 30th, 2026|Endpoints News|
EU lobby urges member states to improve Europe’s life sciences sector news2026-06-29T17:18:33+00:00June 29th, 2026|Endpoints News|
Sobi receives CRL for gout combination drug over manufacturing news2026-06-29T11:00:38+00:00June 29th, 2026|Endpoints News|
Achieve Life Sciences gets a CRL; UPS invests $48M in healthcare logisticsnews2026-06-25T14:30:04+00:00June 25th, 2026|Endpoints News|
Trump backs psychedelics, but CDMOs hold back for nownews2026-06-23T16:00:33+00:00June 23rd, 2026|Endpoints News|
After ‘redesign,’ WuXi Biologics sets new timeline for Massachusetts factory completionnews2026-06-22T15:40:54+00:00June 22nd, 2026|Endpoints News|
Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50Mnews2026-06-18T15:28:19+00:00June 18th, 2026|Endpoints News|
WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military listnews2026-06-12T11:21:11+00:00June 12th, 2026|Endpoints News|
Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec saysnews2026-06-11T15:30:23+00:00June 11th, 2026|Endpoints News|
Camurus’ second CRL for acromegaly drug; Teva details workforce cutsnews2026-06-11T14:45:20+00:00June 11th, 2026|Endpoints News|
